Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Adamis Pharmaceuticals ada
AddedMar 20, 2024
UpdatedJun 18, 2026
Adamis Pharmaceuticals ada

Adamis Pharmaceuticals ada

Public

San Diego-based medical organization developing products for allergy, opioid overdose, and respiratory diseases.

HQ
San Diego, CA, US
Overview
Compare
Employees

DMK Pharmaceuticals Corporation, based in San Diego, focuses on developing and commercializing products for allergy, opioid overdose, respiratory, and inflammatory diseases. Their lead product candidate, DPI-125, targets opioid use disorder. They also offer SYMJEPI, an epinephrine injection for emergency allergic reactions.

The company has made significant strides in clinical trials and product development, particularly with DPI-125 and SYMJEPI. Their work addresses critical medical needs, impacting patient care and treatment options in their specialized fields.

Adamis Pharmaceuticals ada - Similar Companies

DMK Pharmaceuticals logo

DMK Pharmaceuticals

Indivior logo

Indivior

indivior.com

AdrenaCard logo

AdrenaCard

adrenacard.com

DiaMedica Therapeutics logo

DiaMedica Therapeutics

diamedica.com

ARS Pharmaceuticals logo

ARS Pharmaceuticals

ars-pharma.com

ImprimisRx logo

ImprimisRx

imprimisrx.com

Amydis logo

Amydis

amydis.com

Durect logo

Durect

durect.com

DemeRx logo

DemeRx

demerx.com

DMD Therapeutics logo

DMD Therapeutics

OrphoMed logo

OrphoMed

Amexdrug logo

Amexdrug

amexdrug.com

Microneb logo

Microneb

microneb.com

Bryn Pharma logo

Bryn Pharma

brynpharma.com

Defender Pharmaceuticals logo

Defender Pharmaceuticals

defenderpharma.com

Adamis Pharmaceuticals ada - Quick Facts

Who are Adamis Pharmaceuticals ada's competitors?

Companies similar to Adamis Pharmaceuticals ada include DMK Pharmaceuticals, Indivior, AdrenaCard and DiaMedica Therapeutics.

Where is Adamis Pharmaceuticals ada's headquarters located?

Adamis Pharmaceuticals ada's headquarters is located in San Diego, CA, US.

How many employees does Adamis Pharmaceuticals ada have?

Adamis Pharmaceuticals ada has 11 employees as of Feb 6, 2024.

Adamis Pharmaceuticals ada - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified